Manuel Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally, Ron L Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion Fokkert, Cornelia Haug, Rolf Hinzmann, Johan Jendle, David C Klonoff, Julia K Mader, Konstantinos Makris, Othmar Moser, James Nichols, Kirsten Norgaard, John Pemberton, Elizabeth Selvin, Loukia Spanou, Andreas Thomas, Nam Tran, Lilian Witthauer, Robbert J Slingerland, Guido Freckmann
Comparing the performance of different continuous glucose monitoring (CGM) systems is challenging due to the lack of comprehensive guidelines for clinical study design. In particular, the absence of concise requirements for the distribution of comparator (reference) blood glucose (BG) concentrations and their rate of change (RoC), that are used to evaluate CGM performance, impairs comparability. For this article, several experts in the field of CGM performance testing have collaborated to propose characteristics of the distribution of comparator measurements that should be collected during CGM performance testing...
January 9, 2024: Diabetes Technology & Therapeutics